The Fibrotic Role of Phosphatidylinositol-3-kinase/Akt Pathway in Injured Skeletal Muscle After Acute Contusion
Overview
Affiliations
Transforming growth factor β (TGF-β) is a multifunctional cytokine with fibrogenic properties. Previous studies demonstrated that Phosphatidylinositol 3-Kinase (PI3K)/Akt/ mammalian target of Ramycin (mTOR), a non-Smad TGF-β pathway, plays an important role in the fibrotic pathogenesis of different organs such as the lung, kidney, skin and liver. However, the role of PI3k-Akt pathway in fibrosis in injured skeletal muscle is still unclear. In this study, we determined the fibrotic role of PI3K-Akt pathway in injured skeletal muscle. We established a mouse model for acute muscle contusion. Western blotting analysis showed that TGF-β, phosphorylated Akt and phosphorylated mTOR were increased in muscles after acute contusion, which indicated that the PI3K-Akt- mTOR pathway was activated in skeletal muscle after acute contusion. The pathway was inhibited by a PI3K inhibitor, LY294002. Moreover, the expression of fibrosis markers vimentin, α SMA and collagen I and the area of scar decreased in injured skeletal muscle after PI3K pathway was blocked. The muscle function improved in terms of both fast-twitch and tetanic strength after PI3K/Akt pathway was inhibited in injured skeletal muscle. In conclusion, activation of PI3K-Akt-mTOR pathway might promote collagen production and scar formation in the acute contused skeletal muscle. Blocking of PI3K-Akt-mTOR pathway could improve the function of injured skeletal muscle.
Eldien H, Alenzi M Afr Health Sci. 2024; 23(4):371-381.
PMID: 38974297 PMC: 11225483. DOI: 10.4314/ahs.v23i4.40.
Fang X, Yin Y, Lun H, Su S, Zhu S PeerJ. 2023; 11:e16588.
PMID: 38077437 PMC: 10710175. DOI: 10.7717/peerj.16588.
Deng P, Qiu S, Liao F, Jiang Y, Zheng C, Zhu Q Exp Biol Med (Maywood). 2022; 247(17):1577-1590.
PMID: 35775612 PMC: 9554171. DOI: 10.1177/15353702221102376.
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics.
Dolivo D, Weathers P, Dominko T Acta Pharm Sin B. 2021; 11(2):322-339.
PMID: 33643815 PMC: 7893118. DOI: 10.1016/j.apsb.2020.09.001.
Ronning S, Carlson C, Aronsen J, Pisconti A, Host V, Lunde M Front Cell Dev Biol. 2020; 8:730.
PMID: 32850844 PMC: 7411008. DOI: 10.3389/fcell.2020.00730.